FDA Rips 'Troubling' Drug Promo In Repeat Warning Letter
For the second time in three years, Kadmon Pharmaceuticals LLC has sent promotional literature with faulty information on safety and effectiveness, a "particularly troubling" repeat offense, the U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article